Mays Cancer Center new members
Mays Cancer Center Annual Report
The Mays Cancer Center is an Organized Research Unit of UT Health San Antonio. As a National Cancer Institute-designated Cancer Center, Mays Cancer Center has a formal membership policy in support of the center’s mission to promote interdisciplinary research in cancer-related areas of basic science, clinical research and cancer prevention and control, and to foster the application of the results of that research in the community setting, especially in the South Texas community served by the center. Mays Cancer Center members include those who serve as a principal investigator on a National Institutes of Health research project grant or other equivalent peer-reviewed, cancer-related grant or who are a principal or co-investigator of cancer center clinical trials.
Mays Cancer Center welcomes the following new members from Fiscal Year 2022.
Carissia Calvo-Strube, MD, Assistant Professor, Division of Surgical Oncology, Breast Oncology
Research interests: surgical interventions in breast cancer
Marcela Mazo Canola, MD, Assistant Professor, Department of Medicine, Division of Hematology/Medical Oncology, Breast Oncology
Research interests: development of new therapeutics in breast cancer
Vaida Glatt, PhD, Assistant Professor, Department of Orthopaedic Surgery
Research interests: development of novel therapeutics for the treatment of bone cancers
Rueben Harris, PhD, Chair, Department of Biochemistry and Structural Biology
Research interests: contribution of apolipoprotein B mRNA editing enzyme, catalytic polypeptides (APOBEC) to cancer progression and tumor evolution, from the initial stages of transformation to the later stages of metastasis and therapy resistance
Gang Huang, PhD, Professor, Department of Cell Systems and Anatomy
Research interests: genetic and epigenetic regulators and signaling pathways involved in hematological malignancies
Lingtao Jin, PhD, Associate Professor, Department of Molecular Medicine
Research interests: understanding the signaling basis of cancer metabolism, with focus on the function of metabolic enzymes and onco-metabolites in cancer and therapy resistance
Supreet Kaur, MD, Assistant Professor, Department of Medicine, Division of Hematology/Medical Oncology, Lymphoma/Thoracic Oncology
Research interests: development of new therapeutics for lymphoma and thoracic cancers
William Kelly, MD, Assistant Professor, Department of Medicine, Division of Hematology/Medical Oncology, Neuro-oncology and Thoracic Oncology
Research interests: development of new therapeutics in brain and thoracic cancers
Debra Kent, DNP, Director, Survivorship Care
Research interests: survivorship resources for patients with cancer
Alexander V. Mazin, PhD, Professor, Department of Biochemistry and Structural Biology
Research interests: the role of DNA repair in cancer development and progression
Devi Meyyappan, MD, Assistant Professor, Department of Medicine, Division of Hematology/Medical Oncology, Head and Neck Cancers
Research interests: development of new therapeutics in head and neck cancers
Neil Newman, MD, MS, Assistant Professor, Department of Radiation Oncology, Gastrointestinal Oncology
Research interests: development of new radiation oncology treatments for gastrointestinal cancers
Zohra Nooruddin, MD, Associate Professor, Department of Medicine, Division of Hematology/Medical Oncology, Hematology/Oncology and Palliative Medicine
Research interests: development of new therapeutics in hematological malignancies
Shruti Pandita, MD, Assistant Professor, Department of Medicine, Division of Hematology/Medical Oncology, Gastrointestinal Oncology
Research interests: development of new therapeutics for gastrointestinal cancers
Lixin Song, PhD, Professor, School of Nursing
Research interests: smart design to enhance survivorship care and health outcomes for patients with cancer and their family caregivers during post-treatment care transitions
Xiaoli Sun, MD, PhD, Assistant Professor, Department of Pharmacology
Research interests: understanding the pathophysiology and identifying novel therapeutic targets for liver cancer
Elizabeth Wasmuth, PhD, Assistant Professor, Department of Biochemistry and Structural Biology
Research interests: therapeutic targets in prostate cancer
Murali Yallapu, PhD, Assistant Professor, Department of Immunology and Microbiology
Research interests: development of nanomedicine for cancer progression
Mansour Zadeh, PhD, Distinguished Professor, Department of Medicine, Division of Gastroenterology
Research interests: microbiome and mucosal biology in cancer
Peng Zhao, PhD, Assistant Professor, Department of Biochemistry and Structural Biology
Research interests: understanding the causes of the heterogeneous pathology of nonalcoholic steatohepatitis (NASH) with the goal of identifying novel targets to reverse and prevent its progression to hepatocellular carcinoma
Daohong Zhou, MD, Professor, Department of Biochemistry and Structural Biology; Co-director, Drug Discovery and Structural Biology Shared Resource
Research interests: developing additional specific antitumor and better senolytic agents using the proteolysis targeting chimera (PROTAC) drug development platform
